A comparison of 7 Tesla MR spectroscopic imaging and 3 Tesla MR fingerprinting for tumor localization in glioma patients
暂无分享,去创建一个
Vienna | Krems | Department of Functional Imaging | M. Preusser | D. Neurology | S. Trattnig | W. Bogner | J. Furtner | G. Widhalm | Bernhard Strasser | L. Hingerl | M. U. O. Vienna | W. Marik | Sukrit Sharma | Artificial Intelligence | T. Roetzer-Pejrimovsky | Musculoskeletal Radiology | P. Cardoso | C. Cadrien | P. Lazen | Divisionof Oncology | A. Lipka | Austria | Karl Rossler | Gilbert Hangel High-field MR Center | Image-guided Therapy | Department for Neurosurgery | Christian Doppler Laboratory for MR Imaging Biomarkers | Division of Neuropathology | Neurochemistry | Division of Neuroradiology | Research Center for Medical Image Analysis | Danube Private University | I. DepartmentofInternalMedicine | Institute for Clinical Molecular Mri | Karl Landsteiner Society | St. Polten | M. Radiology | K. Society
[1] Moss Y. Zhao,et al. Advanced MR Techniques for Preoperative Glioma Characterization: Part 2 , 2023, Journal of magnetic resonance imaging : JMRI.
[2] Moss Y. Zhao,et al. Advanced MR Techniques for Preoperative Glioma Characterization: Part 1 , 2023, Journal of magnetic resonance imaging : JMRI.
[3] B. Moffat,et al. Application of 7T MRS to High-Grade Gliomas , 2022, American Journal of Neuroradiology.
[4] M. Preusser,et al. 7T HR FID-MRSI Compared to Amino Acid PET: Glutamine and Glycine as Promising Biomarkers in Brain Tumors , 2022, Cancers.
[5] M. Harada,et al. In vivo Human MR Spectroscopy Using a Clinical Scanner: Development, Applications, and Future Prospects , 2022, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[6] M. Nittka,et al. MR Fingerprinting—A Radiogenomic Marker for Diffuse Gliomas , 2022, Cancers.
[7] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[8] R. Kreis,et al. Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts' consensus recommendations , 2021, NMR in biomedicine.
[9] M. Preusser,et al. High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI , 2020, NeuroImage: Clinical.
[10] S. Trattnig,et al. Clinical High-Resolution 3D-MR Spectroscopic Imaging of the Human Brain at 7 T. , 2019, Investigative radiology.
[11] M. Griswold,et al. Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors , 2019, Pediatric Neurosurgery.
[12] K. Glunde,et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer , 2019, NMR in biomedicine.
[13] B. Mädler,et al. Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients. , 2017, Oncotarget.
[14] Wolfgang Bogner,et al. Simultaneous mapping of metabolites and individual macromolecular components via ultra‐short acquisition delay 1H MRSI in the brain at 7T , 2017, Magnetic resonance in medicine.
[15] W. Peng,et al. Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions , 2016, Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society.
[16] Wolfgang Bogner,et al. Mapping of brain macromolecules and their use for spectral processing of 1H-MRSI data with an ultra-short acquisition delay at 7T , 2015, NeuroImage.
[17] I. Amelio,et al. Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.
[18] J. Duerk,et al. Magnetic Resonance Fingerprinting , 2013, Nature.
[19] C. Thompson,et al. Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.
[20] R. Deberardinis,et al. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.
[21] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.